Influence of tobacco consumption on the values of different insulin resistance risk scales and non-alcoholic fatty liver disease and hepatic fibrosis scales in 418,343 spanish people

• Miguel Carlos Aguiló Juanola ; Ángel Arturo López-González ^[1] ; Pilar Tomás-Gil ^[1] ; Hernán Paublini ^[1] ; Pedro J. Tárraga López ^[2] ; José Ignacio Ramírez-Manent ^{[1] [3] [1]}
  1. [1] Universitat de les Illes Balears

     Universitat de les Illes Balears

     Palma de Mallorca, España

     
  2. [2] Faculty of Medicine, University of Castilla la Mancha
  3. [3] Mallorca Primary Care

  Mostrar afiliaciones +
• Localización: Academic Journal of Health Sciences: Medicina Balear, ISSN-e 2255-0560, Vol. 39, Nº. 2, 2024, págs. 9-15
• Idioma: inglés
• DOI: 10.3306/AJHS.2024.39.02.9
• Títulos paralelos:
  • Influencia del consumo de tabaco en los valores de diferentes escalas de riesgo de resistencia a la insulina y de enfermedad de hígado graso no alcohólico y fibrosis hepática en 418.343 españoles
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    Introducción y objetivos: La resistencia a la insulina (RI) y la enfermedad del hígado graso no alcohólico (EHGNA) son dos patologías muy frecuentes que son responsables de la aparición de diferentes cuadros patológicos. En la génesis de ambos procesos intervienen multitud de factores. El objetivo de este estudio es valorar la influencia de diversos factores sociodemográficos como la edad, el sexo o la clase social y el consumo de tabaco en la RI y en la EHGNA.

    Metodología: Estudio descriptivo y transversal realizado en 418343 trabajadores españoles en el que se valora la relación entre variables sociodemográficas y consumo de tabaco con escalas de riesgo de RI, EHGNA y fibrosis hepática.

    Resultados: Todas las variables analizadas influyen en la aparición de RI, EHGNA y fibrosis hepática, especialmente la edad y el sexo.

    Ser varón, de edad avanzada, pertenecer a la clase social III y ser fumador incrementan el riesgo de RI, EHGNA y fibrosis hepática.

    Conclusiones: Todas las variables sociodemográficas analizadas y el consumo de tabaco influyen en la aparición de RI, EHGNA y fibrosis hepática.

  • English

    Introduction and objectives: Insulin resistance (IR) and non-alcoholic fatty liver disease (NAFLD) are two very frequent pathologies that are responsible for the appearance of different pathological conditions. A multitude of factors are involved in the genesis of both processes. The aim of this study was to assess the influence of various sociodemographic factors such as age, sex, social class, and tobacco consumption on IR and NAFLD.

    Methodology: A descriptive, cross-sectional study carried out in 418343 Spanish workers in which the relationship between sociodemographic variables and tobacco consumption with risk scales for IR, NAFLD, and liver fibrosis was assessed.

    Results: All the variables analyzed influence the appearance of IR, NAFLD, and liver fibrosis, especially age and sex. Being male, of advanced age, belonging to social class III, and being a smoker increased the risk of IR, NAFLD, and liver fibrosis.

    Conclusions: All the sociodemographic variables analyzed, and tobacco use influence the occurrence of IR, NAFLD, and liver fibrosis.

• Referencias bibliográficas
  • Lee SH, Park SY, Choi CS. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. 2022 Jan;46(1):15-37. doi: 10.4093/dmj.2021.0280.
  • Shu Y, Wu X, Wang J, Ma X, Li H, Xiang Y. Associations of Dietary Inflammatory Index With Prediabetes and Insulin Resistance. Front Endocrinol...
  • Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, et al. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM),...
  • Takano C, Ogawa E, Hayakawa S. Insulin Resistance in Mitochondrial Diabetes. Biomolecules. 2023 Jan 7;13(1):126. doi: 10.3390/ biom13010126.
  • Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review...
  • Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis...
  • Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic...
  • Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis...
  • Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N. Challenges and opportunities in NASH drug development. Nat Med. 2023 Mar;29(3):562-73....
  • Zheng D, Li H, Ai F, Sun F, Singh M, Cao X, et al. Association between the triglyceride to high-density lipoprotein cholesterol ratio and the...
  • Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated...
  • Huang X, He J, Wu G, Peng Z, Yang B, Ye L. TyG-BMI and hypertension in Normoglycemia subjects in Japan: A cross-sectional study. Diab Vasc...
  • Mirr M, Braszak-Cymerman A, Ludziejewska A, Kręgielska-Narożna M, Bogdański P, Bryl W, et al. Serum Asprosin Correlates with Indirect Insulin...
  • Yan S, Wang D, Jia Y. Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study. Hormones (Athens). 2023...
  • Widjaja NA, Irawan R, Hanindita MH, Ugrasena I, Handajani R. METS- IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents. J Med Invest....
  • Kamari N, Fateh HL, Darbandi M, Najafi F, Moradi M, Pasdar Y. Fatty liver index relationship with biomarkers and lifestyle: result from RaNCD...
  • Preveden T, Veres B, Ruzic M, Pete M, Bogic S, Kovacevic N, et al. Triglyceride-Glucose Index and Hepatic Steatosis Index for the assessment...
  • Li X, Qin P, Cao L, Lou Y, Shi J, Zhao P, et al. Dose-response association of the ZJU index and fatty liver disease risk: A large cohort in...
  • Wu N, Zhai X, Feng M, Li J, Yu N, Zhang F, et al. The gender-specific bidirectional relations between chronic diseases and total bilirubin/urea in...
  • Ebrahimi M, Seyedi SA, Nabipoorashrafi SA, Rabizadeh S, Sarzaeim M, Yadegar A, et al. Lipid accumulation product (LAP) index for the diagnosis...
  • Saran M, Sharma JK, Ranjan A, Deka S, Sabharwal M, Palukari S, et al. A retrospective study to find out the correlation between NAFLD, diabetes,...
  • Domingo-Salvany A, Bacigalupe A, Carrasco JM, Espelt A, Ferrando J, Borrell C; del Grupo de Determinantes Sociales de Sociedad Española de...
  • Li X, Wang J, Niu L, Tan Z, Ma J, He L, et al. Prevalence estimates of the insulin resistance and associated prevalence of heart failure among United...
  • Goh LPW, Sani SA, Sabullah MK, Gansau JA. The Prevalence of Insulin Resistance in Malaysia and Indonesia: An Updated Systematic Review and...
  • Resistencia a la insulina, qué es y prevalencia (webconsultas.com)
  • Pollak F, Araya V, Lanas A, Sapunar J. II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina. Rev...
  • De Paoli M, Zakharia A, Werstuck GH. The Role of Estrogen in Insulin Resistance: A Review of Clinical and Preclinical Data. Am J Pathol. 2021...
  • Palmisano BT, Zhu L, Stafford JM. Role of Estrogens in the Regulation of Liver Lipid Metabolism. Adv Exp Med Biol. 2017;1043:227-256. doi: 10.1007/978-3-319-70178-3_12.
  • Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018 Sep;15:45-55. doi: 10.1016/j.molmet.2018.05.008.
  • Buitrago-Lopez A, van den Hooven EH, Rueda-Clausen CF, Serrano N, Ruiz AJ, Pereira MA, Mueller NT. Socioeconomic status is positively associated...
  • Murakami K, Sasaki S, Takahashi Y, Uenishi K; Japan Dietetic Students’ Study for Nutrition and Biomarkers Group. Neighborhood socioeconomic...
  • Mohammadi R, Goodarzi-Khoigani M, Allameh Z, Mazloomy Mahmoodabad SS, Baghiani Moghadam MH, Nadjarzadeh A, et al. Association between Socioeconomic...
  • Mukharjee S, Bank S, Maiti S. Chronic Tobacco Exposure by Smoking Develops Insulin Resistance. Endocr Metab Immune Disord Drug Targets. 2020;20(6):869-77....
  • Adhami N, Starck SR, Flores C, Martins Green M. A Health Threat to Bystanders Living in the Homes of Smokers: How Smoke Toxins Deposited on...
  • PLOS ONE Editors. Expression of Concern: A Health Threat to Bystanders Living in the Homes of Smokers: How Smoke Toxins Deposited on Surfaces...
  • Martínez-Almoyna E, Tomás-Gil P, Coll-Villalonga JL, Ramírez- Manent JI, Riera K, López-González AA., Variables that influence the values...
  • Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review...
  • Vilar-Gomez E, Nephew LD, Vuppalanchi R, Gawrieh S, Mladenovic A, Pike F, et al. High-quality diet, physical activity, and college education are...
  • Premkumar M, Anand AC. Tobacco, Cigarettes, and the Liver: The Smoking Gun. J Clin Exp Hepatol. 2021 Nov-Dec;11(6):700-12. doi: 10.1016/j.jceh.2021.07.016.